Nivocasan
- Generic Name
- Nivocasan
- Drug Type
- Small Molecule
- Chemical Formula
- C21H22FN3O5
- CAS Number
- 908253-63-4
- Unique Ingredient Identifier
- 9554OW6MVU
- Background
Nivocasan has been used in trials studying the treatment of HCV Infection and Nonalcoholic Steatohepatitis.
Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection
- First Posted Date
- 2009-04-03
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 307
- Registration Number
- NCT00874796
Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)
Phase 2
Completed
- Conditions
- Nonalcoholic Steatohepatitis
- Interventions
- Drug: GS-9450 Placebo
- First Posted Date
- 2008-08-25
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 124
- Registration Number
- NCT00740610
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV
- First Posted Date
- 2008-07-31
- Last Posted Date
- 2014-06-19
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 33
- Registration Number
- NCT00725803
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath